Twice-daily dosing of loracarbef 200 mg versus 400 mg in the treatment of patients with acute maxillary sinusitis
- 1 April 1995
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 17 (2) , 214-230
- https://doi.org/10.1016/0149-2918(95)80020-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: